Elizabeth Sweeney, MD has received an NCI STTR Phase I award for her project titled "Engineered Glioblastoma-Specific T Cells Using Immunostimulatory Photothermal Nanoparticles." This grant will support her work in developing a novel T cell-based therapy for treating glioblastoma.